Woodside Energy Stock Price Edges Higher After Beaumont Handover, Lower-Carbon Delay Caps Gains

March 26, 2026
Woodside Energy Stock Price Edges Higher After Beaumont Handover, Lower-Carbon Delay Caps Gains

NEW YORK, March 26, 2026, 17:28 EDT

Woodside Energy Group’s U.S.-listed shares were up about 0.7% at $23.82 in late Thursday dealings after the Australian producer said it had taken operational control of the Beaumont New Ammonia facility in Texas from OCI Global. Reuters-delayed data put the Sydney-listed stock at A$34.24, up 1.8%, earlier in the day. 1

That matters now for a simple reason. Liz Westcott only got the top job last week, and Beaumont is one of the first operating markers under her watch as Woodside moves through a heavy project slate. 2

Then there is the commodity backdrop. Brent settled at $108.01 a barrel on Thursday, while Asian liquefied natural gas (LNG) prices have jumped 143% since Feb. 28 as war-related disruption hit Qatar and the Strait of Hormuz, tightening supply and lifting the appeal of exporters outside the Gulf. 3

Beaumont itself is not small. Woodside put the plant’s capacity at up to 1.1 million tonnes of ammonia a year, said output began in December, and said it had already signed offtake agreements — advance sales contracts — at prevailing market prices for conventional supply. 4

The snag is the lower-carbon stream. At a briefing this month, Westcott said demand still looked strong but was “slower to build up”, and that third-party feedstock work needed for lower-carbon supply was running behind schedule. 5

That split has fed the stock story too. Reuters reported Woodside, Santos and Norway’s Equinor have outperformed broader energy indices as investors buy Western gas suppliers, while U.S. exporter Cheniere has rallied harder. 6

Sector analysts are leaning into the near-term earnings case if prices hold here. “The first quarter is going to be phenomenal for these companies,” Leo Mariani, senior research analyst at Roth Capital Partners, said of big energy producers. 7

But the cleaner bull case has cracks. Woodside flagged a softer 2026 production outlook in January, and Reuters has also warned LNG shares could turn volatile after the latest run even if the market stays tight. 8

Louisiana LNG remains another pressure point. Westcott has called it a priority, and last month Woodside disclosed it was in talks to sell another 20% stake in the project, a move Tim Waterer at KCM Trade called a “smart way” to monetise the asset while easing balance-sheet pressure. 9

Stock Market Today

  • CSL Shares Dive 16% in 2025: Biotech Firm's Position Explained
    March 26, 2026, 5:53 PM EDT. CSL Ltd (ASX:CSL) shares have fallen 16.1% since the start of 2025 amid market volatility. The Australian biotechnology company operates through three units: CSL Behring (blood plasma products), Seqirus (flu and pandemic products), and Vifor (iron deficiency and kidney care). Despite the recent dip, CSL remains attractive for investors due to its stable revenue from essential healthcare products, growth potential driven by rising global healthcare spending especially in the U.S., and appeal to ethical investors focused on sustainable investments. The ASX Healthcare Index has underperformed the broader market over five years, but CSL's consistent dividend payments and sector resilience stand out. Analysts watch dividend yield trends to gauge CSL's valuation amid market shifts.